In our clinical trials, patient centricity and site centricity go hand-in-hand. This means we partner with patients, caregivers and trial site staff to design and conduct our clinical trials. Trial site staff bring important insights and experiences to the table, and they are the ones delivering the patient experience in clinical trials. Together, we can make patient-centric trials possible, and, ultimately, deliver new medicines to patients faster. Learn more about our commitment to clinical trials: https://lnkd.in/etWfE_r7 #ClinicalTrialsDay #CTD2024
Boehringer Ingelheim
Pharmaceutical Manufacturing
Ingelheim am Rhein, Rhineland-Palatinate 1,781,170 followers
About us
Our people are our strength. And, together with over 56,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward
- Website
-
http://www.boehringer-ingelheim.com
External link for Boehringer Ingelheim
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Ingelheim am Rhein, Rhineland-Palatinate
- Type
- Privately Held
- Specialties
- Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing
Locations
Employees at Boehringer Ingelheim
-
Gwen Whitfield Foster
-
Thomas Macauley
Research Data Management - Lab Services Engineer at Boehringer-Ingelheim
-
Mitchell Taub
Highly Distinguished Research Fellow
-
Ralf Schundelmeier
Product Leader (ex Salesforce) - Building Platforms and Applications for Analytics, AI / Machine Learning & Data
Updates
-
Did you know that 20 million people die from cardio-renal-metabolic (CRM) diseases every year? Although these diseases affecting organs such as the heart, kidneys and liver can be connected, they're often treated separately. That's why we develop treatments that consider the whole patient, and the way the body’s systems interact. Take a look ➡️ https://bit.ly/4dhAGiI #AnnualReport #CardioRenalMetabolic
-
-
#PRESS: We have just launched BULTAVO 3™, a new vaccine that protects sheep and cattle against #bluetongue virus serotype 3 (BTV-3). Bluetongue is a transboundary animal disease affecting ruminants, posing a threat to animals, farmers, and public health. BULTAVO 3™ is the first BTV-3 vaccine that prevents both clinical signs of the disease and mortality. Following recent outbreaks in Europe, it is currently licensed for use in the Netherlands. Learn more about our latest vaccine innovation and how it limits the impact of bluetongue: https://lnkd.in/eDV4Bg-c
-
-
#HCP: Dr. Susanne Nicholas discusses the importance of kidney health, and why early and regular testing is key to preventing the progression of #ChronicKidneyDisease (CKD). When testing for CKD, It Takes 2 tests – an eGFR (blood) and UACR (urine) test – to get the full picture. Watch to learn more!
-
Curious to learn how #AI can detect cough in pigs five days earlier than conventional detection methods without a farmer or veterinarian setting a foot in a barn? Then read on and test your ability to identify the severity of respiratory issues in pigs – can you beat AI? 💪 https://bit.ly/3UzylbP #AnnualReport #AnimalHealth
-
-
Having healthy vision is something taken for granted by many. Did you know that diabetes is the leading cause of blindness? Take a look at what we do in our in-house research in diabetic eye diseases as well as through partnerships with biotechs, academic institutions, and advocacy organizations to develop breakthrough treatments and foster awareness. ➡️ https://bit.ly/49SRR7E #AnnualReport #RetinalHealth
-
-
Transboundary animal diseases such as bluetongue, foot-and-mouth disease and avian influenza spread fast, quickly impacting #AnimalHealth, #livestock trade and even food security. They can cause massive global disruptions – but our technology is ready to fight them. 👉 https://lnkd.in/eAttPbDc
-
#NEWS: We're excited to share our positive data from the Phase I/IIa HORNBILL study in diabetic macular ischema (DMI). #RetinalHealth #ARVO2024 Learn more 👉 http://bit.ly/3JUk5nD
-
-
Meet Scooter, a lovely tuxedo cat, who lives with #FelineDiabetes. As our main mission is to improve lives of humans and animals, our R&D team aims to make a difference to the lives of cats like Scooter. Read more in our #AnnualReport ➡️ https://bit.ly/3UfiLki
-
-
Imagine if this is how you saw the world. We’re on a mission to stop vision loss caused by chronic retinal diseases through earlier detection, intervention, and better treatments. Learn more about how we're building a diverse retinal health portfolio focused on the three main drivers of retinal disease: ➡️ Neurodegeneration (when nerve cells in the eye start to break down or die) ➡️ Inflammation ➡️ Vascular dysfunction (when the blood vessels start to fail or get blocked) 👉 https://lnkd.in/gQYEyNC4 #RetinalDiseases #RetinalHealth #Science
-